Lifestyle & Digital Eye Care

The evidence for blue light glasses reducing digital eye strain symptoms is weak. The most rigorous trial to date — a randomised controlled trial published in the Cochrane database — found no significant benefit of blue light filtering lenses for eye strain, headaches, or visual fatigue from screens. This is consistent with the TFOS Digital Eye Strain report position. The reason is that the primary drivers of digital eye strain are reduced blink rate, accommodative fatigue, convergence insufficiency, and dry eye — none of which are caused by blue light wavelengths. Where blue light glasses do have evidence is for evening use — filtering blue light in the 1–2 hours before bed can support melatonin production and improve sleep onset. So: blue light glasses at night, for sleep — reasonable. Blue light glasses during the day, for eye strain — not what the evidence supports. If you are wearing blue light glasses and still have eye strain, the underlying cause has not been addressed.

Evidence-based guidance from the World Health Organisation and the American Academy of Pediatrics is as follows: under 18 months — no screens other than video calls; 18 months to 2 years — limited high-quality content, with a parent present; 2–5 years — maximum 1 hour per day; 6 years and above — consistent limits with an emphasis on content quality, ensuring screens do not displace sleep, physical activity, or face-to-face interaction. For school-age children, the most important protective measures are 90 minutes of outdoor time daily in natural light (the single strongest evidence-based intervention against myopia onset) and no screen use within 1 hour of bedtime. We do not recommend arbitrary hour limits for teenagers — the evidence supports good habits, not rigid numbers. The quality of screen use (active versus passive), the environment (outdoor balance), and the sleep habits matter more than the exact hour count.

At normal indoor screen brightness levels, digital screens do not cause direct retinal or structural eye damage. The blue light emitted by screens is orders of magnitude below the threshold for photochemical retinal injury — which requires sustained exposure to very high-intensity sources (arc welding, direct sun gazing). What screens do cause is functional harm: dry eye from reduced blink rate, accommodative fatigue and spasm from sustained near focus, convergence insufficiency from sustained vergence demand, and — specifically in children — acceleration of myopia progression through reduced outdoor time. These are real and clinically significant harms, but they are functional and largely reversible (or preventable) — not structural retinal damage. The one area of genuine concern is myopia in children: the higher the final myopia, the higher the lifetime risk of retinal detachment and macular degeneration. This is why myopia control in progressing children is a genuine clinical priority — not cosmetic.

Lubricating drops help dry eye that is caused by aqueous deficiency — insufficient tear production. But the most common cause of dry eye in screen users and in air-conditioned environments is evaporative dry eye from meibomian gland dysfunction — where the oil (lipid) layer of the tear film is deficient. When the oil layer is deficient, the aqueous tears evaporate too quickly — no matter how many lubricating drops you add. The drops provide brief comfort and then the tear film breaks down again because the underlying oil layer problem has not been addressed. The correct treatment for evaporative dry eye from MGD is to restore the lipid layer — through warm compresses, lid hygiene, omega-3 supplementation, and in moderate-to-severe cases, prescription cyclosporine or systemic doxycycline. Adding more lubricating drops to MGD-driven dry eye is like adding water to a leaking bath without fixing the plug — temporarily helpful, structurally not addressing the cause.

Not necessarily — and getting stronger glasses may actually be the wrong treatment. Blurred distance vision after prolonged near work that clears after resting is a classic presentation of accommodative spasm or pseudomyopia — where the focusing muscle has locked in a near-focus state after sustained screen use. If a standard (non-cycloplegic) refraction is done while this spasm is active, it will give a falsely high myopic prescription — and correcting to that prescription will lock the spasm in further. The correct investigation is cycloplegic refraction — drops that relax the accommodation fully and reveal the true underlying prescription. At Netram, we perform cycloplegic refraction for all children and for any adult with suspected accommodative spasm. If the cycloplegic result is significantly less minus than the current prescription, the management is very different from simply updating the glasses.

Absolutely, without exception. This is one of the most important messages in diabetes care — and one of the most poorly followed. Diabetic retinopathy can develop and progress significantly before any visual symptoms appear. By the time a diabetic patient notices blurred vision from their retinopathy, the disease has usually reached a stage that is harder to treat and has caused more permanent damage. The evidence is unambiguous: annual dilated retinal examination for all diabetic patients, regardless of how well-controlled their blood sugar is, from 5 years after diagnosis (type 1) or from the time of diagnosis (type 2, where the disease may have been present for years before detection). Good glycaemic control dramatically reduces the risk of retinopathy developing and progressing — but it does not eliminate it. Annual retinal screening is non-negotiable even when HbA1c is at target.

It depends on who you are and what your eye health situation is. Omega-3 fatty acids (EPA and DHA, 2–3g daily from fish oil or algae-based supplements) have good evidence for meibomian gland function and evaporative dry eye — they are worth recommending for confirmed MGD-driven dry eye. Lutein (10mg) and zeaxanthin (2mg) in the AREDS2 formulation have strong evidence for slowing progression of intermediate to advanced age-related macular degeneration — they are a firm recommendation for patients with AMD or those at high risk. For people with healthy eyes and a reasonably balanced diet — no specific supplement has been proven to prevent common eye diseases in the general population. We do not prescribe supplements as a general precaution or because patients read about them online. We prescribe them when there is a specific clinical indication — and we explain exactly what the evidence does and does not show.

Yes — and the details matter. Screen distance: 50–70cm from your eyes (about arm's length). Screen height: the top of the screen should be at or slightly below eye level — not above it. Looking slightly downward reduces the exposed ocular surface area, which reduces tear evaporation. Screen brightness: match the brightness of your screen to the ambient light in the room — a very bright screen in a dark room (or vice versa) creates contrast strain. Anti-reflective coating on glasses is essential for screen work — uncoated lenses create reflections that significantly increase visual fatigue. Font size: large enough that you are not leaning forward to read. Ambient lighting: no bright light source (window, lamp) directly behind the screen or in your field of view — position your desk so windows are to the side, not behind the monitor. Night mode / warm colour temperature: switch to warm display settings after sunset to reduce blue light emission in the evening. These are not trivial changes — patients who implement them consistently report meaningful symptom reduction, particularly when combined with addressing the underlying clinical cause.